Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities:
Net income	$ 4,500	$ 3,465
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	856	829
Provision for bad debts	(161)	418
Compensatory element of stock issuances	7
Stock issued for costs and expenses	2,239
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(1,675)	(2,186)
Notes receivable	12	11
Inventories	(140)	(104)
Prepaid expenses and other current assets	26	73
Other assets	(63)	12
Increase (decrease) in operating liabilities, net:
Accounts payable	50	(187)
Other current liabilities	(2,218)	1,120
Customer advances	(132)	1
Billings in excess of costs and estimated earnings on uncompleted contracts	(30)
Other liabilities	92	16
Due to related medical practices	(9)	(4)
Net cash provided by operating activities	3,354	3,464
Cash Flows from Investing Activities:
Purchases of property and equipment	(599)	(45)
Cost of patents	(43)	(19)
Net cash used in investing activities	(642)	(64)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(1,410)	(623)
Distributions to noncontrolling interests	(1,837)	(1,255)
Repayment of notes receivable from employee stockholders	1	2
Net cash used in financing activities	(3,246)	(1,876)
Net Increase in Cash and Cash Equivalents	(534)	1,524
Cash and Cash Equivalents - Beginning of Period	8,528	9,449
Cash and Cash Equivalents - End of Period	$ 7,994	$ 10,973